Call Us: 888-488-2702

Amgen to buy genetics research firm in Iceland for $415 million

By on Dec 10, 2012 in News |

Amgen, a Thousand Oaks, Calif.-based biotechnology firm, said it entered into a definitive agreement to acquire DeCode Genetics, a biopharmaceutical company in Reykjavik, Iceland, that focuses on human genetics research, in a $415 million cash deal.